Published in J Immunol on June 15, 1987
Cationic and high affinity serum IgG anti-dsDNA antibodies in active lupus nephritis. Clin Exp Immunol (1993) 0.90
IgG3 deficiency extends lifespan and attenuates progression of glomerulonephritis in MRL/lpr mice. Biol Direct (2012) 0.86
Effect of cyclosporin on immune complex deposition in murine glomerulonephritis. Immunology (1991) 0.83
No evidence for an independent role of anti-heparan sulphate reactivity apart from anti-DNA in lupus nephritis. Clin Exp Immunol (1995) 0.75
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Individual Antigenic Specificity of Isolated Antibodies. Science (1963) 7.27
Serum creatinine levels in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis (1998) 5.28
Saturation of the reticuloendothelial system with soluble immune complexes. J Immunol (1974) 3.65
Studies on antigen-antibody complexes. I. Elimination of soluble complexes from rabbit circulation. J Exp Med (1971) 3.51
Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis (1999) 3.09
The macrophage receptor for IgG: number and affinity of binding sites. J Immunol (1973) 2.91
Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol (2001) 2.80
The impact of comorbid and sociodemographic factors on access to renal transplantation. JAMA (1993) 2.54
Long-term survival in renal transplant recipients with graft function. Kidney Int (2000) 2.38
Role of marrow-derived monocytes and mesangial cells in removal of immune complexes from renal glomeruli. J Exp Med (1979) 2.27
In vitro adherence of soluble immune complexes to macrophages. J Exp Med (1972) 2.26
Immunoglobulins in temporal arteries. An immunofluorescent study. Ann Intern Med (1974) 2.02
The glomerular deposition of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 2.01
Survival advantage in Asian American end-stage renal disease patients. Kidney Int (1999) 1.98
Mycophenolate mofetil reduces late renal allograft loss independent of acute rejection. Transplantation (2000) 1.90
The disappearance kinetics of soluble immune complexes prepared with reduced and alkylated antibodies and with intact antibodies in mice. Lab Invest (1976) 1.84
Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest (1989) 1.82
Studies on antigen-antibody complexes. II. Quantification of tissue uptake of soluble complexes in normal and complement-depleted rabbits. J Immunol (1971) 1.77
The molecular basis of self-association of antibodies to IgG (rheumatoid factors) in rheumatoid arthritis. Proc Natl Acad Sci U S A (1974) 1.76
Specificity of recombination of H and L chains from human gamma-G-myeloma proteins. J Exp Med (1965) 1.69
Differences in access to cadaveric renal transplantation in the United States. Am J Kidney Dis (2000) 1.67
Molecular composition and sedimentation characteristics of soluble antigen-antibody complexes. Biochemistry (1972) 1.64
Effect of cortisone on the disappearance kinetics and tissue localization of soluble immune complexes. J Immunol (1975) 1.62
Antigen retention in joint tissues in antigen-induced synovitis. Clin Exp Immunol (1974) 1.61
Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival. Am J Transplant (2001) 1.60
Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol (1989) 1.59
Effect of cationized antibodies in performed immune complexes on deposition and persistence in renal glomeruli. J Exp Med (1982) 1.54
The hyperviscosity syndrome in rheumatoid arthritis due to intermediate complexes formed by self-association of IgG-rheumatoid factors. Arthritis Rheum (1975) 1.54
Antibody-agarose immunoadsorbents: complete removal of classes of immunoglobulins from serum. J Immunol (1971) 1.54
The disappearance kinetics and glomerular deposition of small-latticed soluble immune complexes. Immunology (1982) 1.54
Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup. J Immunol (1991) 1.49
Body size, dose of hemodialysis, and mortality. Am J Kidney Dis (2000) 1.48
Kinetics and mechanisms for removal of circulating single-stranded DNA in mice. J Exp Med (1978) 1.46
Removal of glomerular deposits of immune complexes in mice by administration of excess antigen. Lab Invest (1980) 1.42
Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials (1996) 1.42
Liver cysts in patients with autosomal dominant polycystic kidney disease. Am J Med (1980) 1.41
Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation (1998) 1.35
The distribution of antigenic determinants in rat skin collagen. J Exp Med (1971) 1.35
Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA. J Immunol (1983) 1.34
Diagnostic value of antibodies to filaggrin in rheumatoid arthritis. J Rheumatol (1998) 1.32
Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med (1984) 1.31
Pathophysiology of circulating immune complexes. Arthritis Rheum (1982) 1.28
Binding of albumin to gamma-A-myeloma proteins and Waldenström macroglobulins by disulfide bonds. J Immunol (1967) 1.28
The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med (1993) 1.26
The impact of HLA mismatches on the survival of first cadaveric kidney transplants. N Engl J Med (1994) 1.26
Clearance of circulating DNA-anti-DNA immune complexes in mice. J Exp Med (1982) 1.23
Clearance and tissue uptake of immune complexes in complement-depleted and control mice. Immunology (1981) 1.20
Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest (1990) 1.20
The molecular basis of self-association of IgG-Rheumatoid factors. J Immunol (1975) 1.19
IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG. J Exp Med (1985) 1.18
Mortality risk by hemodialyzer reuse practice and dialyzer membrane characteristics: results from the usrds dialysis morbidity and mortality study. Am J Kidney Dis (2001) 1.17
Glomerular lesions in mice transgenic for growth hormone and insulinlike growth factor-I. I. Relationship between increased glomerular size and mesangial sclerosis. Am J Pathol (1990) 1.17
Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group. Hypertension (1997) 1.16
Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA. Clin Exp Immunol (1984) 1.15
Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol (1996) 1.15
Fate of preformed immune complexes in rabbits and rhesus monkeys. J Exp Med (1971) 1.14
Determination of soluble immune complex molar composition and antibody association constants by ammonium sulfate precipitation. J Immunol (1974) 1.14
7S M-globulin in rheumatoid arthritis. Evaluation of its clinical significance. Arthritis Rheum (1971) 1.13
Studies on the antigenic determinants in the self-association of IgG rheumatoid factor. J Exp Med (1981) 1.12
Precipitating antigen-antibody systems are required for the formation of subepithelial electron-dense immune deposits in rat glomeruli. J Exp Med (1983) 1.11
Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2002) 1.11
Hospitalizations for bacterial septicemia after renal transplantation in the united states. Am J Nephrol (2001) 1.11
Rearrangement of immune complexes in glomeruli leads to persistence and development of electron-dense deposits. J Exp Med (1983) 1.09
Nonimmunospecific protein-protein interactions of IgG: studies of the binding of IgG to IgG immunoadsorbents. J Immunol (1978) 1.08
Physicochemical and functional relationships of immune complexes. J Invest Dermatol (1980) 1.07
Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q. J Clin Invest (1988) 1.07
Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. The Hemodialysis (HEMO) Study. Kidney Int (1997) 1.07
Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases. Arthritis Rheum (1989) 1.05
Intermediate complexes formed by self-association of IgG-rheumatoid factors. Ann N Y Acad Sci (1975) 1.05
Self-associating IgG rheumatoid factors in MRL/l autoimmune mice. Arthritis Rheum (1984) 1.04
Glomerular localization of preformed immune complexes prepared with anionic antibodies or with cationic antigens. Lab Invest (1984) 1.03
Prescription of twice-weekly hemodialysis in the USA. Am J Nephrol (1999) 1.02
Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival. Clin Nephrol (2001) 1.02
Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol (2001) 1.02
IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis (1985) 1.01
Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation (2000) 1.01
Relationship of dialysis membrane and cause-specific mortality. Am J Kidney Dis (1999) 1.01
Renal transplantation in end-stage sickle cell nephropathy. Transplantation (1999) 1.01
Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. Am J Kidney Dis (2001) 1.00
Serum sickness secondary to treatment with the murine-human chimeric antibody IDEC-C2B8 (rituximab). Arthritis Rheum (2001) 1.00
Covalent binding of molecules to CNBr-activated agarose: parameters relevant to the activation and coupling reactions. Biochim Biophys Acta (1974) 1.00
Interaction between herpes simplex type 1-induced Fc receptor and human and rabbit immunoglobulin G (IgG) domains. Immunology (1986) 1.00
Rheumatoid factors from patients with rheumatoid arthritis possess private repertoires of idiotypes. J Immunol (1987) 1.00
Evaluation of immunological specificity of flurescein-conjugated antisera with agarose-antigen sections. Infect Immun (1975) 1.00
Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis (2001) 0.99
Rheumatoid factors in rheumatoid arthritis. Bull Rheum Dis (1973) 0.98
Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system. Clin Exp Immunol (1982) 0.98
Effect of preformed immune complexes on the clearance and tissue localization of single-stranded DNA in mice. Clin Exp Immunol (1980) 0.98
Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells. Rheumatol Int (1983) 0.97
Mechanisms of tissue deposition of immune complexes. J Rheumatol Suppl (1987) 0.96
Autoantibodies to the collagen-like region of C1Q deposit in glomeruli via C1Q in immune deposits. Clin Immunol Immunopathol (1991) 0.96
Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus. Medicine (Baltimore) (1987) 0.96
Effect of dialysis membranes and middle molecule removal on chronic hemodialysis patient survival. Am J Kidney Dis (1999) 0.95